Articles

Bristol Myers Squibb’s cell therapy Breyanzi won FDA approval Thursday for treatment of a common type of leukemia.

Hibbett’s stock fell premarket Friday after the company, which is working with Nike, missed earnings expectations in its latest quarter.

Jon Gray said interest rate cuts are set to lift real estate prices, creating opportunities for investors

Piper Sandler upgraded Rivian shares to a bullish rating, calling the company’s new lineup “just so cool.”

Bitcoin slumped on Friday, with the cryptocurrency extending its decline from the record high reached this week.

“I also buy all the groceries and household items.”

The Ringling show has returned, but can it compete in the ‘Eras Tour’ era?

Investors will focus increasingly on the next three phases of the AI trade says Goldman Sachs

Bond yields were steady Friday, after a big rise on Thursday after hotter-than-forecast producer price data.

Apple has reportedly acquired a Canadian artificial intelligence startup, ahead of the company’s planned rollout later this year.

U.S. stock futures were pointing to a steady start Friday, with worries that inflation will linger capping momentum after a hot start to the year.

Large stakes in two undervalued German carmakers have put a wrench in the shares of holding company Porsche SE.